
Regeneron buys 23andMe out of bankruptcy
Drugmaker’s takeover comes less than two months after start-up filed for protection
Full Article
Drugmaker’s takeover comes less than two months after start-up filed for protection
Full ArticleDrugmaker’s takeover could raise privacy concerns among genetics start-up’s 15mn users